Researchers have identified a new chemical compound, DE19725241, that shows potential in targeting the fat mass and obesity-associated protein (FTO) to treat pancreatic cancer. According to a study published in BIO Integration, the compound demonstrated selective antiproliferative activity in pancreatic cancer cell lines by binding to specific protein sites, offering a potential new scaffold for … Read more
Researchers at the University of Massachusetts Amherst have developed an artificial intelligence model called MycoPermeNet to accelerate the discovery of tuberculosis drugs. By combining this AI with a high-throughput screening technique known as PAC-MAN, the team can predict which chemical compounds can penetrate the bacterium’s unique mycomembrane, potentially speeding up the search for effective treatments … Read more
Breakthrough in Antibiotic Resistance: Targeting Bacterial Enzymes How the Study Uncovered a New Approach Antibiotic resistance, a global health crisis linked to 4.7 million deaths in 2019, has seen a critical breakthrough. Researchers at Scripps Research discovered that disabling a bacterial enzyme called secreted antigen A (SagA) makes vancomycin-resistant Enterococcus faecium (VREfm) vulnerable to vancomycin. … Read more
Exposure to glyphosate, the active ingredient in many weed killers, is linked to changes in hormones that support pregnancy and fetal development, according to a University of Michigan School of Public Health study. Researchers observed shifts in estriol, thyroid hormones, and corticotropin-releasing hormone among 752 pregnant women in Puerto Rico. How does glyphosate exposure affect … Read more
Monash University researchers found that the copper compound Cu(ATSM) increases brain clearance pumps by 24.1%, reducing toxic amyloid-beta proteins by 42%. According to a study published in ACS Chemical Neuroscience, this treatment repairs the blood-brain barrier and improves spatial learning by nearly 44% in Alzheimer’s disease models. How does Cu(ATSM) repair the brain’s waste-clearing system? … Read more
Researchers at ETH Zurich have identified a new chemical compound, dubbed “Compound 10,” that shows potential in slowing the progression of Alzheimer’s disease by targeting the enzyme GRK2. According to findings published in Cell Reports Medicine, the substance prevents the formation of harmful enzyme aggregates in brain cells, offering a distinct mechanism compared to existing … Read more
The Dawn of the Single-Encounter Radical Cure: Redefining Malaria Treatment For decades, the fight against malaria has been a game of attrition. We treat the symptoms, we clear the blood, but the parasite often finds a way to hide, waiting in the liver to trigger a relapse. However, a breakthrough in chemical engineering is shifting … Read more
Beyond Inhibition: The Shift Toward Total Protein Elimination For decades, the gold standard of drug discovery has been inhibition. The goal was simple: find a protein causing disease and block its activity. However, this approach has a fundamental flaw—it leaves the disease-causing protein intact, often allowing the cell to find a workaround or develop resistance. … Read more
The Double-Edged Sword: Navigating the Risks of GLP-1 Weight Loss and Diabetes Drugs The booming popularity of drugs like semaglutide and tirzepatide, initially designed for type 2 diabetes, has surged thanks to their remarkable weight loss effects. But as millions embrace these medications, a clearer picture of their potential side effects and long-term risks is … Read more
The Future of Drug Design: Beyond Binding Affinity to Enthalpy and Entropy For decades, drug discovery has largely focused on how tightly a molecule binds to its target. But a paradigm shift is underway, driven by a deeper understanding of the thermodynamic forces at play. Recent research, spearheaded by Professor Mitsunori Shiroishi at Tokyo University … Read more